{"id":732608,"date":"2023-02-17T09:04:28","date_gmt":"2023-02-17T14:04:28","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-rad-to-participate-in-citis-2023-healthcare-services-medtech-tools-hcit-conference\/"},"modified":"2023-02-17T09:04:28","modified_gmt":"2023-02-17T14:04:28","slug":"bio-rad-to-participate-in-citis-2023-healthcare-services-medtech-tools-hcit-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-rad-to-participate-in-citis-2023-healthcare-services-medtech-tools-hcit-conference\/","title":{"rendered":"Bio-Rad to Participate in Citi\u2019s 2023 Healthcare Services, MedTech, Tools &amp; HCIT Conference"},"content":{"rendered":"<p>        <!--body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p><b>Bio-Rad to Participate in Citi\u2019s 2023 Healthcare Services, MedTech, Tools &amp; HCIT Conference<\/b><\/p>\n<p>HERCULES, Calif.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nBio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced that the company\u2019s management will participate in a fireside chat event during Citi\u2019s 2023 Healthcare Services, MedTech, Tools &amp; HCIT Conference on Thursday, March 2, 2023, at 11:45 AM Eastern Time (8:45 AM Pacific Time).\n<\/p>\n<p>\nA link to a live webcast and a subsequent replay of the event will be available in the Investor Relations section of Bio-Rad\u2019s website at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bio-rad.com&amp;esheet=53330389&amp;newsitemid=20230217005088&amp;lan=en-US&amp;anchor=bio-rad.com&amp;index=1&amp;md5=7314170f47c08c9d8e1d321d357117a1\">bio-rad.com<\/a>.\n<\/p>\n<p><b>About Bio-Rad<\/b><\/p>\n<p>\nBio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With 70 years of focus on quality and customer service, our products advance the scientific discovery process and improve healthcare. Our customers are universities, research institutions, hospitals, biotechnology and pharmaceutical companies, as well as public health and commercial laboratories including food safety and environmental quality testing facilities. Based in Hercules, California, Bio-Rad has a global network of operations with approximately 8,300 employees worldwide and $2.8 billion in revenues in 2022. For more information, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bio-rad.com%2F&amp;esheet=53330389&amp;newsitemid=20230217005088&amp;lan=en-US&amp;anchor=bio-rad.com&amp;index=2&amp;md5=8fd19efb7adbc0b2413bf4a3c33bf1ca\">bio-rad.com<\/a>.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230217005088r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20230217005088\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20230217005088\/en\/<\/a><\/span><\/p>\n<p><b>Investor Contact:<br \/>\n<\/b><br \/>Edward Chung, Investor Relations<br \/>\n<br \/>510-741-6104<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:ir@bio-rad.com\">ir@bio-rad.com<\/a><\/p>\n<p><b>Media Contact:<br \/>\n<\/b><br \/>Anna Gralinska, Corporate Communications<br \/>\n<br \/>510-741-6643<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:cc@bio-rad.com\">cc@bio-rad.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America California<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Medical Devices Medical Supplies Hospitals Clinical Trials Health Technology Biotechnology Health Pharmaceutical General Health<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230217005088\/en\/618489\/3\/Logo_RGB_on_transpar.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Bio-Rad to Participate in Citi\u2019s 2023 Healthcare Services, MedTech, Tools &amp; HCIT Conference HERCULES, Calif.&#8211;(BUSINESS WIRE)&#8211; Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced that the company\u2019s management will participate in a fireside chat event during Citi\u2019s 2023 Healthcare Services, MedTech, Tools &amp; HCIT Conference on Thursday, March 2, 2023, at 11:45 AM Eastern Time (8:45 AM Pacific Time). A link to a live webcast and a subsequent replay of the event will be available in the Investor Relations section of Bio-Rad\u2019s website at bio-rad.com. About Bio-Rad Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in developing, manufacturing, and marketing a broad range of innovative &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bio-rad-to-participate-in-citis-2023-healthcare-services-medtech-tools-hcit-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Bio-Rad to Participate in Citi\u2019s 2023 Healthcare Services, MedTech, Tools &amp; HCIT Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-732608","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Bio-Rad to Participate in Citi\u2019s 2023 Healthcare Services, MedTech, Tools &amp; HCIT Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bio-rad-to-participate-in-citis-2023-healthcare-services-medtech-tools-hcit-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bio-Rad to Participate in Citi\u2019s 2023 Healthcare Services, MedTech, Tools &amp; HCIT Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Bio-Rad to Participate in Citi\u2019s 2023 Healthcare Services, MedTech, Tools &amp; HCIT Conference HERCULES, Calif.&#8211;(BUSINESS WIRE)&#8211; Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced that the company\u2019s management will participate in a fireside chat event during Citi\u2019s 2023 Healthcare Services, MedTech, Tools &amp; HCIT Conference on Thursday, March 2, 2023, at 11:45 AM Eastern Time (8:45 AM Pacific Time). A link to a live webcast and a subsequent replay of the event will be available in the Investor Relations section of Bio-Rad\u2019s website at bio-rad.com. About Bio-Rad Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in developing, manufacturing, and marketing a broad range of innovative &hellip; Continue reading &quot;Bio-Rad to Participate in Citi\u2019s 2023 Healthcare Services, MedTech, Tools &amp; HCIT Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/bio-rad-to-participate-in-citis-2023-healthcare-services-medtech-tools-hcit-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-17T14:04:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230217005088r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-rad-to-participate-in-citis-2023-healthcare-services-medtech-tools-hcit-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-rad-to-participate-in-citis-2023-healthcare-services-medtech-tools-hcit-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Bio-Rad to Participate in Citi\u2019s 2023 Healthcare Services, MedTech, Tools &amp; HCIT Conference\",\"datePublished\":\"2023-02-17T14:04:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-rad-to-participate-in-citis-2023-healthcare-services-medtech-tools-hcit-conference\\\/\"},\"wordCount\":277,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-rad-to-participate-in-citis-2023-healthcare-services-medtech-tools-hcit-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230217005088r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-rad-to-participate-in-citis-2023-healthcare-services-medtech-tools-hcit-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-rad-to-participate-in-citis-2023-healthcare-services-medtech-tools-hcit-conference\\\/\",\"name\":\"Bio-Rad to Participate in Citi\u2019s 2023 Healthcare Services, MedTech, Tools &amp; HCIT Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-rad-to-participate-in-citis-2023-healthcare-services-medtech-tools-hcit-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-rad-to-participate-in-citis-2023-healthcare-services-medtech-tools-hcit-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230217005088r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2023-02-17T14:04:28+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-rad-to-participate-in-citis-2023-healthcare-services-medtech-tools-hcit-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-rad-to-participate-in-citis-2023-healthcare-services-medtech-tools-hcit-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-rad-to-participate-in-citis-2023-healthcare-services-medtech-tools-hcit-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230217005088r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230217005088r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-rad-to-participate-in-citis-2023-healthcare-services-medtech-tools-hcit-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bio-Rad to Participate in Citi\u2019s 2023 Healthcare Services, MedTech, Tools &amp; HCIT Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bio-Rad to Participate in Citi\u2019s 2023 Healthcare Services, MedTech, Tools &amp; HCIT Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-rad-to-participate-in-citis-2023-healthcare-services-medtech-tools-hcit-conference\/","og_locale":"en_US","og_type":"article","og_title":"Bio-Rad to Participate in Citi\u2019s 2023 Healthcare Services, MedTech, Tools &amp; HCIT Conference - Market Newsdesk","og_description":"Bio-Rad to Participate in Citi\u2019s 2023 Healthcare Services, MedTech, Tools &amp; HCIT Conference HERCULES, Calif.&#8211;(BUSINESS WIRE)&#8211; Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced that the company\u2019s management will participate in a fireside chat event during Citi\u2019s 2023 Healthcare Services, MedTech, Tools &amp; HCIT Conference on Thursday, March 2, 2023, at 11:45 AM Eastern Time (8:45 AM Pacific Time). A link to a live webcast and a subsequent replay of the event will be available in the Investor Relations section of Bio-Rad\u2019s website at bio-rad.com. About Bio-Rad Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in developing, manufacturing, and marketing a broad range of innovative &hellip; Continue reading \"Bio-Rad to Participate in Citi\u2019s 2023 Healthcare Services, MedTech, Tools &amp; HCIT Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-rad-to-participate-in-citis-2023-healthcare-services-medtech-tools-hcit-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2023-02-17T14:04:28+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230217005088r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-rad-to-participate-in-citis-2023-healthcare-services-medtech-tools-hcit-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-rad-to-participate-in-citis-2023-healthcare-services-medtech-tools-hcit-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Bio-Rad to Participate in Citi\u2019s 2023 Healthcare Services, MedTech, Tools &amp; HCIT Conference","datePublished":"2023-02-17T14:04:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-rad-to-participate-in-citis-2023-healthcare-services-medtech-tools-hcit-conference\/"},"wordCount":277,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-rad-to-participate-in-citis-2023-healthcare-services-medtech-tools-hcit-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230217005088r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-rad-to-participate-in-citis-2023-healthcare-services-medtech-tools-hcit-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-rad-to-participate-in-citis-2023-healthcare-services-medtech-tools-hcit-conference\/","name":"Bio-Rad to Participate in Citi\u2019s 2023 Healthcare Services, MedTech, Tools &amp; HCIT Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-rad-to-participate-in-citis-2023-healthcare-services-medtech-tools-hcit-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-rad-to-participate-in-citis-2023-healthcare-services-medtech-tools-hcit-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230217005088r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2023-02-17T14:04:28+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-rad-to-participate-in-citis-2023-healthcare-services-medtech-tools-hcit-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/bio-rad-to-participate-in-citis-2023-healthcare-services-medtech-tools-hcit-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-rad-to-participate-in-citis-2023-healthcare-services-medtech-tools-hcit-conference\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230217005088r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230217005088r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-rad-to-participate-in-citis-2023-healthcare-services-medtech-tools-hcit-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Bio-Rad to Participate in Citi\u2019s 2023 Healthcare Services, MedTech, Tools &amp; HCIT Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/732608","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=732608"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/732608\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=732608"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=732608"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=732608"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}